home All News open_in_new Full Article

Teva Announces $2,000,000,000 (Equivalent) Debt Tender Offers For Notes Due 2026

TEL AVIV, Israel, May 19, 2025 (GLOBE NEWSWIRE) — Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) (“Teva”) announced today that it has commenced tender offers (the “Offers”) to purchase for cash for a combined aggregate purchase price (exclusive of accrued and unpaid interest) of up to $2,000,000,000 (equivalent) (the “Total Maximum Amount”) of the […]


today 4 w. ago attach_file Economics

attach_file Events
attach_file Economics
attach_file Economics
attach_file Economics
attach_file Economics
attach_file Economics
attach_file Economics
attach_file Economics
attach_file Economics
attach_file Economics
attach_file Economics
attach_file Culture
attach_file Other
attach_file Economics
attach_file Other
attach_file Economics
attach_file Economics
attach_file Economics
attach_file Other


ID: 298827447
Add Watch Country

arrow_drop_down